FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: PILL

  • Home
  •  | 
  • Tag Archives: "PILL"

Canntab to Enter Medicinal Cannabis Market in Mexico

Canntab to Enter Medicinal Cannabis Market in Mexico
Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) today announced the signing of a non-binding Letter of Intent (the “LOI”) with Labsco Promedic SA de CV of Monterrey, Mexico (“Labsco”) for the establishment of a joint venture relationship for the sales & distribution of Canntab products in Mexico (the “Territory”) on an exclusive basis.
Read more

Canntab Files Application to Become Licensed Producer

Canntab Files Application to Become Licensed Producer
Oct. 19, 2018 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE:PILL) (“Canntab” or the “Company”), a leader in the development of precision oral dose cannabis tablets and capsules, is pleased to announce that it has filed an application to become a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (the “License”), and that it received confirmation from Health Canada that its application had been received. The License, if granted by Health Canada, would allow the Company to process cannabis products at its current production facility in Markham, Ontario with minimal additional capital expenditures as compared to a new purpose-built facility.
Read more

Canntab enters distribution, supply deal with NewCanna

Canntab enters distribution, supply deal with NewCanna
Canntab Therapeutics Ltd. has completed a non-binding letter of intent with NewCanna SAS of Bogota, Colombia, for the establishment of a significant bilateral relationship for the sale and distribution of Canntab's products. The territory applicable to the agreement is the countries of Colombia, Chile, Paraguay and Spain. The agreement will grant NewCanna the right to sell and distribute certain Canntab exclusive proprietary products, and the right to utilize Canntab's know-how and patents in the Territory only.
Read more

FSD Pharma Receives First Delivery of Cantabb Equipment with a Capacity to Manufacture Approx. 1,500,000 Tablets Per Day

FSD Pharma Receives First Delivery of Cantabb Equipment with a Capacity to Manufacture Approx. 1,500,000 Tablets Per Day
Sept. 25, 2018 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) ("FSD Pharma" or the "Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that the Company has received its first delivery of manufacturing equipment at its Cobourg plant from Canntab  Therapeutics Limited (CSE:PILL) ("Canntab"), a leader in the rapidly growing cannabis pill market. The manufacturing equipment consists of a fully GMP High output Tablet press capable of pressing more than 1,500,000 tablets per day, as well as blending machinery, large scale process and drying equipment and packaging equipment.
Read more